Summary: H.R.6038 — 102nd Congress (1991-1992)All Information (Except Text)

There is one summary for H.R.6038. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (09/25/1992)

Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were developed at a qualified nonprofit institution of higher education.